美股异动丨安进涨超5.6%创逾7个月新高，上调全年业绩指引

Core Insights - Amgen (AMGN.US) shares rose over 5.6%, reaching a high of $313.36, marking a new high in over 7 months [1] Financial Performance - In Q3, Amgen's sales increased by 12% year-over-year to $9.56 billion, surpassing analyst expectations of $8.97 billion [1] - Adjusted earnings per share (EPS) were reported at $5.64, exceeding the forecast of $5.01 [1] Guidance Update - The company raised its full-year performance guidance, projecting sales between $35.8 billion and $36.6 billion, and EPS between $20.6 and $21.4 [1]